We developed Zn-Adenine NPs coated with anti-CD305 antibody for the targeted delivery of the lncRNA LEF1-AS1 into rheumatoid RASFs for the treatment of RA. The gene discussed is LAIR1; the disease is rheumatoid arthritis.